AXRX — Amexdrug Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
- $0.03m
- $0.56m
- $9.15m
Annual balance sheet for Amexdrug, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2008 December 31st | 2009 December 31st | 2010 December 31st | C2011 December 31st | 2012 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 0.099 | 0.129 | 0.451 | 0.592 | 0.422 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 0.322 | 0.448 | 0.474 | 0.654 | 0.559 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 0.662 | 0.75 | 1.29 | 1.5 | 1.87 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.016 | 0.018 | 0.014 | 0.05 | 0.489 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 0.709 | 0.798 | 1.34 | 1.6 | 2.41 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 0.654 | 0.735 | 1.09 | 1.25 | 1.64 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.654 | 0.735 | 1.09 | 1.25 | 1.98 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Total Equity | 0.054 | 0.064 | 0.251 | 0.349 | 0.43 |
| Total Liabilities & Shareholders' Equity | 0.708 | 0.798 | 1.34 | 1.6 | 2.41 |
| Total Common Shares Outstanding |